Medac Gesellschaft fuer

Company snapshot

Medac Gesellschaft fuer is a pharma organization headquartered in EU. Primary therapeutic focus areas include Steroid refractory Acute Graft versus host Disease, moderate to severe atopic dermatitis. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (2), phase 1 (1).

• 3 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Medac Gesellschaft fuer. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Medac Gesellschaft fuer.

1. Jun 8, 2026 Clinical update

   MC-FludT.18/QT — Phase 1

2. Jun 8, 2026 Clinical update

   MC-MTX.18/AD — Phase 3

3. Jun 8, 2026 Clinical update

   MC-MSC.1/aGvHD — Phase 3

View all clinical trial activity →

• What is Medac Gesellschaft fuer?

  Medac Gesellschaft fuer is a pharma organization headquartered in EU. Primary therapeutic focus areas include Steroid refractory Acute Graft versus host Disease, moderate to severe atopic dermatitis. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent reco

• Is Medac Gesellschaft fuer publicly traded?

  Medac Gesellschaft fuer appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Medac Gesellschaft fuer develop or market?

  We link 14 drug profile(s) where Medac Gesellschaft fuer is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/medac-gesellschaft-fuer-klinische-spezialpraeparate-mbh#company-drugs.

• What are the latest developments for Medac Gesellschaft fuer?

  In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Medac Gesellschaft fuer focus on?

  Medac Gesellschaft fuer focuses on Steroid refractory Acute Graft versus host Disease, moderate to severe atopic dermatitis based on our analysis of their pipeline programs and drug development activities.